Stereotaxis (STXS) Net Income towards Common Stockholders (2010 - 2026)

Stereotaxis' (STXS) quarterly Net Income towards Common Stockholders came in at -$6.2 million in Q1 2026, down 0.57% year-on-year from -$6.2 million in Q1 2025, and down 5.52% on a QoQ basis from -$5.8 million in Q4 2025.

Stereotaxis (STXS) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$6.2 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 0.57% year-over-year to -$6.2 million in Q1 2026; TTM through Mar 2026 was -$23.0 million, a 13.89% increase from a year earlier, with the FY2025 full-year figure at -$22.9 million, up 9.62% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$6.2 million, down from -$5.8 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for STXS reached as high as -$4.1 million in Q2 2025 and fell as low as -$7.8 million in Q4 2024.
  • Historically, Net Income towards Common Stockholders has averaged -$5.7 million across 5 years, with a median of -$5.7 million in 2023.
  • Across the five-year window, Net Income towards Common Stockholders plunged 253.75% in 2022 and soared 32.71% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$4.5 million in 2022, then dropped by 19.75% to -$5.4 million in 2023, then slumped by 45.73% to -$7.8 million in 2024, then gained by 25.39% to -$5.8 million in 2025, then retreated by 5.52% to -$6.2 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$6.2 million in Q1 2026, -$5.8 million in Q4 2025, and -$6.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -274.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn 22.13 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 239.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn 147.90 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn 13.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -77.90 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn 112.77 Mn
10 Stereotaxis 128.56 Mn 113.94 Mn 3.79 Mn -6.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.17 Mn
Dec 31, 2025 -5.85 Mn
Sep 30, 2025 -6.79 Mn
Jun 30, 2025 -4.14 Mn
Mar 31, 2025 -6.14 Mn
Dec 31, 2024 -7.84 Mn
Sep 30, 2024 -6.52 Mn
Jun 30, 2024 -6.16 Mn
Mar 31, 2024 -4.84 Mn
Dec 31, 2023 -5.38 Mn
Sep 30, 2023 -5.71 Mn
Jun 30, 2023 -5.29 Mn
Mar 31, 2023 -5.68 Mn
Dec 31, 2022 -4.49 Mn
Sep 30, 2022 -5.26 Mn
Jun 30, 2022 -5.47 Mn
Mar 31, 2022 -4.42 Mn
Dec 31, 2021 -3.69 Mn
Sep 30, 2021 -4.96 Mn
Jun 30, 2021 -1.55 Mn